Linden Thomas Advisory Services, LLC

Position in CORT — Corcept Therapeutics Inc

CIK 1965702 Charlotte, NC

Position in CORT

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$3,012,034

+$543,047 QoQ

Shares Held

34,641

-43.4% QoQ

Ownership

0.032%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

#10

of 76 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Linden Thomas Advisory Services, LLC holds $36,440,714 across 14 Biotechnology names. CORT ranks #7 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	176,004	$5,531,805
2	INCY	Incyte Corp	46,507	$5,272,033
3	VRTX	Vertex Pharmaceuticals Inc / Ma	8,103	$4,025,003
4	REGN	Regeneron Pharmaceuticals, Inc.	5,106	$3,183,795
5	EXEL	Exelixis, Inc.	57,943	$3,152,678
6	LGND	Ligand Pharmaceuticals Inc	9,935	$3,140,354
7	CORT	Corcept Therapeutics Inc This page	34,641	$3,012,034
8	VCEL	Vericel Corp	56,051	$2,493,708

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,012,034	34,641	-43.4%	Shares	Sole	2026-07-16
2026-03-31	$2,468,987	61,250	-3.1%	Shares	Sole	2026-04-10
2025-12-31	$2,199,708	63,210	-1.1%	Shares	Sole	2026-01-16
2025-09-30	$5,311,144	63,905	+0.5%	Shares	Sole	2025-11-06
2025-06-30	$4,668,240	63,600	-0.1%	Shares	Sole	2025-07-31
2025-03-31	$7,274,900	63,692	+0.7%	Shares	Sole	2025-04-30
2024-12-31	$3,185,857	63,224	+2.1%	Shares	Sole	2025-01-21
2024-09-30	$2,865,842	61,924	+1.7%	Shares	Sole	2024-10-17
2024-06-30	$1,977,763	60,873	+3.4%	Shares	Sole	2024-07-10
2024-03-31	$1,482,960	58,871	+3.9%	Shares	Sole	2024-04-30
2023-12-31	$1,840,674	56,671	+1.0%	Shares	Sole	2024-02-01
2023-09-30	$1,529,161	56,116	+0.7%	Shares	Sole	2023-10-20
2023-06-30	$1,240,393	55,748	—	Shares	Sole	2023-07-27
No filing history on record for this holder in this stock.